Home › Type 2 Diabetes › California › Torrance
Type 2 Diabetes clinical trials in Torrance, CA
4 studies for Type 2 Diabetes are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
RecruitingPhase 2
- The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Torrance
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
RecruitingHealthy volunteers welcome
- Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center, Torrance
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Atlanta, GA21 studies
- San Diego, CA21 studies
- Boston, MA20 studies
- Miami, FL20 studies
- Chicago, IL19 studies
- Arlington, VA19 studies
- Los Angeles, CA18 studies
- Dallas, TX18 studies
- Columbus, OH17 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer11 studies
- Bladder Cancer8 studies
- Obesity8 studies
- Overweight8 studies
- Cardiovascular Disease7 studies
- Schizophrenia7 studies
- Lung Cancer7 studies
- Metastatic Cancer6 studies
- Coronary Artery Disease4 studies
- Heart Failure4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.